Literature DB >> 17965964

Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency.

Gherardo Mazziotti1, Antonio Bianchi, Vincenzo Cimino, Stefania Bonadonna, Paola Martini, Alessandra Fusco, Laura De Marinis, Andrea Giustina.   

Abstract

Growth hormone deficiency (GHD) in adult patients is associated with marked decrease in bone turnover, low bone mass and high risk of clinical and subclinical fractures. We investigated whether the prevalence of spinal deformities in adults with GHD was related to the gonadal status of patients. A total of 89 adult hypopituitary patients with severe GHD were evaluated for bone mineral density (BMD) and vertebral deformities (quantitative morphometric analysis). At the study entry, 54 patients were eugonadic whereas 35 patients were hypogonadic without replacement treatment. Radiological spinal deformities were found in 55 patients (61.8%) with higher prevalence in untreated (56 cases) versus treated (33 cases) GHD patients. Eugonadic and hypogonadic patients showed no significant difference in spinal deformities although T-score was significantly lower in hypogonadic as compared with eugonadic patients. Gonadal function was not correlated with the occurrence of spinal deformities which was instead inversely correlated with rhGH treatment. In conclusion, gonadal status may influence BMD in adult patients with GHD without affecting the risk to develop vertebral deformities. Conversely, rhGH replacement treatment seems to be the only factor influencing the risk to develop vertebral deformities in adult GHD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17965964     DOI: 10.1007/s11102-007-0069-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  33 in total

Review 1.  Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis.

Authors:  Peter Davidson; Ruairidh Milne; Deborah Chase; Cyrus Cooper
Journal:  Clin Endocrinol (Oxf)       Date:  2004-01       Impact factor: 3.478

Review 2.  Is bone mineral density predictive of fracture risk reduction?

Authors:  Charles A Cefalu
Journal:  Curr Med Res Opin       Date:  2004-03       Impact factor: 2.580

Review 3.  Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

Authors:  A Giustina; J D Veldhuis
Journal:  Endocr Rev       Date:  1998-12       Impact factor: 19.871

4.  The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. .

Authors:  C Wüster; R Abs; B A Bengtsson; H Bennmarker; U Feldt-Rasmussen; E Hernberg-Ståhl; J P Monson; B Westberg; P Wilton
Journal:  J Bone Miner Res       Date:  2001-02       Impact factor: 6.741

5.  Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Delmas; P Burckhardt; C Cooper; D Torgerson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

6.  The minimum effective dose of estrogen for prevention of postmenopausal bone loss.

Authors:  R Lindsay; D M Hart; D M Clark
Journal:  Obstet Gynecol       Date:  1984-06       Impact factor: 7.661

7.  The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.

Authors:  B A Bengtsson; R Abs; H Bennmarker; J P Monson; U Feldt-Rasmussen; E Hernberg-Stahl; B Westberg; P Wilton; C Wüster
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

Review 8.  Glucocorticoid-induced osteoporosis: an update.

Authors:  Gherardo Mazziotti; Alberto Angeli; John P Bilezikian; Ernesto Canalis; Andrea Giustina
Journal:  Trends Endocrinol Metab       Date:  2006 May-Jun       Impact factor: 12.015

9.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group.

Authors:  H K Genant; M Jergas; L Palermo; M Nevitt; R S Valentin; D Black; S R Cummings
Journal:  J Bone Miner Res       Date:  1996-07       Impact factor: 6.741

10.  Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults.

Authors:  P Kann; B Piepkorn; B Schehler; J Andreas; J Lotz; W Prellwitz; J Beyer
Journal:  Clin Endocrinol (Oxf)       Date:  1998-05       Impact factor: 3.478

View more
  11 in total

Review 1.  Effects of hypogonadism on bone metabolism in female adolescents and young adults.

Authors:  Madhusmita Misra
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

2.  Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency.

Authors:  Gherardo Mazziotti; Mauro Doga; Stefano Frara; Filippo Maffezzoni; Teresa Porcelli; Luigi Cerri; Roberto Maroldi; Andrea Giustina
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

Review 3.  The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly.

Authors:  Adnan Ajmal; Arezoo Haghshenas; Shirin Attarian; Maya Barake; Nicholas A Tritos; Anne Klibanski; Karen K Miller; Lisa B Nachtigall
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

4.  Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis.

Authors:  Nicholas A Tritos; Susan L Greenspan; Donna King; Amir Hamrahian; David M Cook; Peter J Jönsson; Michael P Wajnrajch; Maria Koltowska-Häggstrom; Beverly M K Biller
Journal:  J Clin Endocrinol Metab       Date:  2011-03-02       Impact factor: 5.958

5.  Influence of diabetes mellitus on vertebral fractures in men with acromegaly.

Authors:  Gherardo Mazziotti; Monica Gola; Antonio Bianchi; Teresa Porcelli; Antonella Giampietro; Vincenzo Cimino; Mauro Doga; Carmine Gazzaruso; Laura De Marinis; Andrea Giustina
Journal:  Endocrine       Date:  2011-05-19       Impact factor: 3.633

6.  High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas.

Authors:  Gherardo Mazziotti; Tatiana Mancini; Marilda Mormando; Ernesto De Menis; Antonio Bianchi; Mauro Doga; Teresa Porcelli; Pier Paolo Vescovi; Laura De Marinis; Andrea Giustina
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

7.  Vertebral fractures in males with prolactinoma.

Authors:  Gherardo Mazziotti; Teresa Porcelli; Marilda Mormando; Ernesto De Menis; Antonio Bianchi; Carola Mejia; Tatiana Mancini; Laura De Marinis; Andrea Giustina
Journal:  Endocrine       Date:  2011-04-10       Impact factor: 3.633

8.  Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome.

Authors:  W Vena; F Carrone; G Mazziotti; A Ferlin; A Delbarba; O Akpojiyovbi; L C Pezzaioli; P Facondo; C Cappelli; L Leonardi; L Balzarini; D Farina; A Pizzocaro; A G Lania
Journal:  J Endocrinol Invest       Date:  2022-08-28       Impact factor: 5.467

Review 9.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 10.  Update on vertebral fractures in pituitary diseases: from research to clinical practice.

Authors:  Flaminia Carrone; Salvatore Ariano; Sara Piccini; Davide Milani; Marco Mirani; Luca Balzarini; Andrea Gerardo Lania; Gherardo Mazziotti
Journal:  Hormones (Athens)       Date:  2021-02-19       Impact factor: 2.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.